Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions
International Journal of Cancer · 2024-11 · 155 (9) · 1549-1557
DOI: 10.1002/ijc.35044 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Cancer, online erschienen am 27.05.2024. Verfasst von Karolina Louvanto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Papillomavirus Vaccines, Papillomavirus Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program.
Abstract (Originalsprache)
Cervical cancer screening programs, including triage tests, need redesigning as human papillomavirus (HPV)‐vaccinated women are entering the programs. Methylation markers offer a potential solution to reduce false‐positive rates by identifying clinically relevant cervical lesions with progressive potential. In a nested case–control study, 9242 women who received the three‐dose HPV16/18‐vaccine at ages 12–15 or 18 in a community‐randomized trial were included. Subsequently, they were re‐randomized for either frequent or infrequent cervical cancer screening trials. Over a 15‐year post‐vaccination follow‐up until 2022, 17 high‐grade squamous intraepithelial lesion (HSIL) and 15 low‐grade (LSIL) cases were identified at the 25‐year screening round, alongside 371 age and community‐matched HPV16/18‐vaccinated controls. Methylation analyses were performed on cervical samples collected at age 25, preceding histologically confirmed LSIL or HSIL diagnoses. DNA methylation of viral (HPV16/18/31/33) and host‐cell genes ( EPB41L3 , FAM19A4 , and miR124‐2) was measured, along with HPV‐genotyping. No HPV16/18 HSIL cases were observed. The predominant HPV‐genotypes were HPV52 (29.4%), HPV59/HPV51/HPV58 (each 23.5%), and HPV33 (17.7%). Methylation levels were generally low, with no significant differences in mean methylation levels of viral or host‐cell genes between the LSIL/HSIL and controls. However, a significant difference in methylation levels was found between HSIL cases and controls when considering a combination of viral genes and EPB41L3 ( p value = .0001). HPV‐vaccinated women with HSIL had HPV infections with uncommon HPV types that very rarely cause cancer and displayed low methylation levels. Further investigation is warranted to understand the likely regressive nature of HSIL among HPV‐vaccinated women and its implications for management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
- Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
- Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
- Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden.
- Centre for Cancer Screening, Prevention and Early Detection (SPED), Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
ORCID-Profile: Karolina Louvanto, Lisanne Verhoef, Ville Pimenoff, Penelope Gray, Joakim Dillner, Matti Lehtinen
Förderung
- European Union's Horizon 2020 research and innovation program
Zitieren
APA
Louvanto, K., Verhoef, L., Pimenoff, V., Eriksson, T., Leppälä, S., Lagheden, C., Gray, P., Scibior-Bentkowska, D., Sumiec, E., Nieminen, P., Dillner, J., Berkhof, J., Meijer, C. J. L. M., Lehtinen, M., Nedjai, B., & Heideman, D. A. M. (2024). Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions. International Journal of Cancer, 155(9), 1549-1557. https://doi.org/10.1002/ijc.35044
Vancouver
Louvanto K, Verhoef L, Pimenoff V, Eriksson T, Leppälä S, Lagheden C, et al. Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions. International Journal of Cancer. 2024;155(9):1549-1557. doi:10.1002/ijc.35044
BibTeX
@article{Louvanto2024,
author = {Louvanto, Karolina and Verhoef, Lisanne and Pimenoff, Ville and Eriksson, Tiina and Leppälä, Siiri and Lagheden, Camilla and Gray, Penelope and Scibior-Bentkowska, Dorota and Sumiec, Elizabeth and Nieminen, Pekka and Dillner, Joakim and Berkhof, Johannes and Meijer, Chris J L M and Lehtinen, Matti and Nedjai, Belinda and Heideman, Daniëlle A M},
title = {Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions},
journal = {International Journal of Cancer},
year = {2024},
volume = {155},
number = {9},
pages = {1549--1557},
doi = {10.1002/ijc.35044}
}
EUVIMED